| 1 |
石炳毅,贾晓伟,李宁.中国移植后糖尿病诊疗技术规范(2019版)[J].器官移植, 2019, 10(1):1-9.
|
| 2 |
Sun H, Saeedi P, Karuranga S, et al. IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045[J]. Diabetes Res Clin Pract, 2022, 183:109119.
|
| 3 |
Cole JB, Florez JC. Genetics of diabetes mellitus and diabetes complications[J]. Nat Rev Nephrol, 2020, 16(7):377-390.
|
| 4 |
Wan XX, Zhang DY, Khan MA, et al. Stem cell transplantation in the treatment of type 1 diabetes mellitus: from insulin replacement to beta-cell replacement[J]. Front Endocrinol (Lausanne), 2022, 13:859638.
|
| 5 |
Wang S, Lei B, Zhang E, et al. Targeted therapy for inflammatory diseases with mesenchymal stem cells and their derived exosomes: from basic to clinics[J]. Int J Nanomedicine, 2022, 17:1757-1781.
|
| 6 |
Shin L, Peterson DA. Impaired therapeutic capacity of autologous stem cells in a model of type 2 diabetes[J]. Stem Cells Transl Med, 2012, 1(2):125-135.
|
| 7 |
Policha A, Zhang P, Chang L, et al. Endothelial differentiation of diabetic adipose-derived stem cells[J]. J Surg Res, 2014, 192(2):656-663.
|
| 8 |
Bacakova L, Zarubova J, Travnickova M, et al. Stem cells: their source, potency and use in regenerative therapies with focus on adipose-derived stem cells-a review[J]. Biotechnol Adv, 2018, 36(4):1111-1126.
|
| 9 |
Jiao Z, Ma Y, Liu X, et al. Adipose-derived stem cell transplantation attenuates inflammation and promotes liver regeneration after ischemia-reperfusion and hemihepatectomy in swine[J]. Stem Cells Int, 2019, 2019:2489584.
|
| 10 |
Andjelkov K, Eremin II, Korac A. Different levels of EGF, VEGF, IL-6, MCP-1, MCP-3, IP-10, eotaxin and MIP-1alpha in the adipose-derived stem cell secretome in androgenetic alopecia[J]. Exp Dermatol, 2022, 31(6):936-942.
|
| 11 |
Zorena K, Michalska M, Kurpas M, et al. Environmental factors and the risk of developing type 1 diabetes-old disease and new data[J]. Biology (Basel), 2022, 11(4):608.
|
| 12 |
Omar SA, Abdul-Hafez A, Ibrahim S, et al. Stem-cell therapy for bronchopulmonary dysplasia (BPD) in newborns[J]. Cells, 2022, 11(8):1275.
|
| 13 |
Nojehdehi S, Soudi S, Hesampour A, et al. Immunomodulatory effects of mesenchymal stem cell-derived exosomes on experimental type-1 autoimmune diabetes[J]. J Cell Biochem, 2018, 119(11):9433-9443.
|
| 14 |
Gunawardena TNA, Rahman MT, Abdullah BJJ, et al. Conditioned media derived from mesenchymal stem cell cultures: The next generation for regenerative medicine[J]. J Tissue Eng Regen Med, 2019, 13(4):569-586.
|
| 15 |
Hashemi SM, Hassan ZM, Hossein-Khannazer N, et al. Investigating the route of administration and efficacy of adipose tissue-derived mesenchymal stem cells and conditioned medium in type 1 diabetic mice[J]. Inflammopharmacology, 2020, 28(2):585-601.
|
| 16 |
Mohammadi Ayenehdeh J, Niknam B, Rasouli S, et al. Immunomodulatory and protective effects of adipose tissue-derived mesenchymal stem cells in an allograft islet composite transplantation for experimental autoimmune type 1 diabetes[J]. Immunol Lett, 2017, 188:21-31.
|
| 17 |
Amer MG, Embaby AS, Karam RA, et al. Role of adipose tissue derived stem cells differentiated into insulin producing cells in the treatment of type I diabetes mellitus[J]. Gene, 2018, 654:87-94.
|
| 18 |
Dave SD, Vanikar AV, Trivedi HL, et al. Novel therapy for insulin-dependent diabetes mellitus: infusion of in vitro-generated insulin-secreting cells[J]. Clin Exp Med, 2015, 15(1):41-45.
|
| 19 |
Saeedi P, Petersohn I, Salpea P, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the international diabetes federation diabetes atlas, 9(th) edition[J]. Diabetes Res Clin Pract, 2019, 157:107843.
|
| 20 |
Kaneto H, Kimura T, Shimoda M, et al. Molecular mechanism of pancreatic beta-cell failure in type 2 diabetes mellitus[J]. Biomedicines, 2022, 10(4):818.
|
| 21 |
Biondi G, Marrano N, Borrelli A, et al. Adipose tissue secretion pattern influences beta-cell wellness in the transition from obesity to type 2 diabetes[J]. Int J Mol Sci, 2022, 23(10):5522.
|
| 22 |
Deng Z, Xu H, Zhang J, et al. Infusion of adiposederived mesenchymal stem cells inhibits skeletal muscle mitsugumin 53 elevation and thereby alleviates insulin resistance in type 2 diabetic rats[J]. Mol Med Rep, 2018, 17(6):8466-8474.
|
| 23 |
Wang M, Song L, Strange C, et al. Therapeutic effects of adipose stem cells from diabetic mice for the treatment of type 2 diabetes[J]. Mol Ther, 2018, 26(8):1921-1930.
|
| 24 |
Elshemy MM, Asem M, Allemailem KS, et al. Antioxidative capacity of liver- and adipose-derived mesenchymal stem cell-conditioned media and their applicability in treatment of type 2 diabetic rats[J]. Oxid Med Cell Longev, 2021, 2021:8833467.
|
| 25 |
Xue B, Xiao X, Yu T, et al. Mesenchymal stem cells modified by FGF21 and GLP1 ameliorate lipid metabolism while reducing blood glucose in type 2 diabetic mice[J]. Stem Cell Res Ther, 2021, 12(1):133.doi: 10.1186/s13287-021-02205-z.
|
| 26 |
Sun LL, Liu TJ, Li L, et al. Transplantation of betatrophin-expressing adipose-derived mesenchymal stem cells induces beta-cell proliferation in diabetic mice[J]. Int J Mol Med, 2017, 39(4):936-948.
|
| 27 |
张新, 周玉红, 白云. 自体脂肪干细胞移植治疗2型糖尿病的安全性及有效性[J]. 中国医科大学学报, 2015, 44(12):1137-1141.
|
| 28 |
Nakamura K, Miyoshi T, Yoshida M, et al. Pathophysiology and treatment of diabetic cardiomyopathy and heart failure in patients with diabetes mellitus[J]. Int J Mol Sci, 2022, 23(7):3587. doi: 10.3390/ijms23073587.
|
| 29 |
Seferović PM, Petrie MC, Filippatos GS, et al. Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology[J]. Eur J Heart Fail, 2018, 20(5):853-872.
|
| 30 |
Yakupova EI, Maleev GV, Krivtsov AV, et al. Macrophage polarization in hypoxia and ischemia/reperfusion: Insights into the role of energetic metabolism[J]. Exp Biol Med, 2022, 247(11):958-971.
|
| 31 |
Zhao J, Chen XD, Yan ZZ, et al. Gut-derived exosomes induce liver injury after intestinal ischemia/reperfusion by promoting hepatic macrophage polarization[J]. Inflammation, 2022，45(6):2325-2338.
|
| 32 |
Jin L, Deng Z, Zhang J, et al. Mesenchymal stem cells promote type 2 macrophage polarization to ameliorate the myocardial injury caused by diabetic cardiomyopathy[J]. J Transl Med, 2019, 17(1):251.doi: 10.1186/s12967-019-1999-8.
|
| 33 |
Hu C, Li L. The application of resveratrol to mesenchymal stromal cell-based regenerative medicine[J]. Stem Cell Res Ther, 2019, 10(1):307.doi: 10.1186/s13287-019-1412-9.
|
| 34 |
Wu M, Ma L, Xue L, et al. Resveratrol alleviates chemotherapy-induced oogonial stem cell apoptosis and ovarian aging in mice[J]. Aging (Albany NY), 2019, 11(3):1030-1044.
|
| 35 |
Chen TS, Chuang SY, Shen CY, et al. Antioxidant Sirt1/Akt axis expression in resveratrol pretreated adipose-derived stem cells increases regenerative capability in a rat model with cardiomyopathy induced by diabetes mellitus[J]. J Cell Physiol, 2021, 236(6):4290-4302.
|
| 36 |
Fujita Y, Haneda M. Clinical practice of diabetic foot, nephropathy, and retinopathy in Japan: cross-sectional study using local and nationwide questionnaire surveys[J]. Diabetol Int, 2021, 13(3):493-502.
|
| 37 |
Ludwig PE, Freeman SC, Janot AC. Novel stem cell and gene therapy in diabetic retinopathy, age related macular degeneration, and retinitis pigmentosa[J]. Int J Retina Vitreous, 2019, 5:7. doi: 10.1186/s40942-019-0158-y.
|
| 38 |
Elshaer SL, Evans W, Pentecost M, et al. Adipose stem cells and their paracrine factors are therapeutic for early retinal complications of diabetes in the Ins2(Akita) mouse[J]. Stem Cell Res Ther, 2018, 9(1):322. doi: 10.1186/s13287-018-1059-y.
|
| 39 |
Gu C, Zhang H, Gao Y. Adipose mesenchymal stem cells-secreted extracellular vesicles containing microRNA-192 delays diabetic retinopathy by targeting ITGA1[J]. J Cell Physiol, 2021, 236(7):5036-5051.
|
| 40 |
Jere SW, Houreld NN. Regulatory processes of the canonical Wnt/beta-catenin pathway and photobiomodulation in diabetic wound repair[J]. Int J Mol Sci, 2022, 23(8):4210. doi: 10.3390/ijms23084210.
|
| 41 |
Sun Y, Song L, Zhang Y, et al. Adipose stem cells from type 2 diabetic mice exhibit therapeutic potential in wound healing[J]. Stem Cell Res Ther, 2020, 11(1):298.doi: 10.1186/s13287-020-01817-1.
|
| 42 |
De Gregorio C, Contador D, Díaz D, et al. Human adipose-derived mesenchymal stem cell-conditioned medium ameliorates polyneuropathy and foot ulceration in diabetic BKS db/db mice[J]. Stem Cell Res Ther, 2020, 11(1):168.doi: 10.1186/s13287-020-01680-0.
|
| 43 |
Chen L, Qu J, Mei Q, et al. Small extracellular vesicles from menstrual blood-derived mesenchymal stem cells (MenSCs) as a novel therapeutic impetus in regenerative medicine[J]. Stem Cell Res Ther, 2021, 12(1):433. doi: 10.1186/s13287-021-02511-6.
|
| 44 |
Pomatto M, Gai C, Negro F, et al. Differential therapeutic effect of extracellular vesicles derived by bone marrow and adipose mesenchymal stem cells on wound healing of diabetic ulcers and correlation to their cargoes[J]. Int J Mol Sci, 2021, 22(8):3851. doi: 10.3390/ijms22083851.
|
| 45 |
Xu H, Zhao B, Zhong W, et al. Identification of miRNA signature associated with erectile dysfunction in type 2 diabetes mellitus by support vector machine-recursive feature elimination[J]. Front Genet, 2021, 12:762136.doi: 10.3389/fgene.2021.762136.
|
| 46 |
Pakpahan C, Ibrahim R, William W, et al. Stem cell therapy and diabetic erectile dysfunction: A critical review[J]. World J Stem Cells, 2021, 13(10):1549-1563.
|
| 47 |
Zhu LL, Huang X, Yu W, et al. Transplantation of adipose tissue-derived stem cell-derived exosomes ameliorates erectile function in diabetic rats[J]. Andrologia, 2018, 50(2).doi: 10.1111/and.12871.
|
| 48 |
Shan HT, Zhang HB, Chen WT, et al. Combination of low-energy shock-wave therapy and bone marrow mesenchymal stem cell transplantation to improve the erectile function of diabetic rats[J]. Asian J Androl, 2017, 19(1):26-33.
|
| 49 |
Chen S, Zhu J, Wang M, et al. Comparison of the therapeutic effects of adipose-derived and bone marrow mesenchymal stem cells on erectile dysfunction in diabetic rats[J]. Int J Mol Med, 2019, 44(3):1006-1014.
|
| 50 |
Zhang HB, Chen FZ, He SH, et al. In vivo tracking on longer retention of transplanted myocardin gene-modified adipose-derived stem cells to improve erectile dysfunction in diabetic rats[J]. Stem Cell Res Ther, 2019, 10(1):208. doi: 10.1186/s13287-019-1325-7.
|
| 51 |
Zhang Y, Yang J, Zhuan L, et al. Transplantation of adipose-derived stem cells overexpressing inducible nitric oxide synthase ameliorates diabetes mellitus-induced erectile dysfunction in rats[J]. Peerj, 2019, 7:e7507. doi: 10.7717/peerj.7507.
|
| 52 |
Quaade ML, Dhumale P, Steffensen SGC, et al. Adipose-derived stem cells from type 2 diabetic rats retain positive effects in a rat model of erectile dysfunction[J]. Int J Mol Sci, 2022, 23(3):1692. doi: 10.3390/ijms23031692.
|